LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM was reported 304476 times

LEVOTHYROXINE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 356 0.6380
1 IMMUNISATION 232 0.5346
2 PALMOPLANTAR KERATODERMA 348 0.4800
3 BLOOD THYROID STIMULATING HORMONE ABNORMAL 775 0.4203
4 SENSITISATION 224 0.2951
5 THYROID FUNCTION TEST ABNORMAL 1144 0.2751
6 C-REACTIVE PROTEIN 247 0.2665
7 THYROIDECTOMY 448 0.2578
8 BLOOD THYROID STIMULATING HORMONE INCREASED 2288 0.2484
9 BLOOD THYROID STIMULATING HORMONE DECREASED 1089 0.2395
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 408 0.2037
11 ATRIAL TACHYCARDIA 414 0.1970
12 SEDATION COMPLICATION 495 0.1938
13 BLOOD PRESSURE SYSTOLIC ABNORMAL 418 0.1690
14 POLYCYSTIC OVARIES 256 0.1649
15 PRURITUS GENITAL 385 0.1633
16 BLOOD PRESSURE DIASTOLIC ABNORMAL 407 0.1599
17 CREATININE RENAL CLEARANCE DECREASED 558 0.1393
18 AUTOIMMUNE THYROIDITIS 512 0.1353
19 SCHIZOAFFECTIVE DISORDER 240 0.1345
20 HYPOTHYROIDISM 4197 0.1313
21 SWOLLEN JOINT COUNT INCREASED 403 0.1263
22 CAROTID ARTERY OCCLUSION 454 0.1243
23 TENSION HEADACHE 477 0.1108
24 THYROID DISORDER 1672 0.1084
25 RHEUMATIC FEVER 475 0.1065
26 RHINITIS ALLERGIC 463 0.1039
27 C-REACTIVE PROTEIN ABNORMAL 666 0.1037
28 GOITRE 401 0.0978
29 PERSONALITY DISORDER 255 0.0973
30 SLEEP TERROR 388 0.0921
31 THYROID NEOPLASM 243 0.0880
32 FACET JOINT SYNDROME 277 0.0850
33 BLOOD PRESSURE DIASTOLIC DECREASED 615 0.0832
34 RHEUMATOID FACTOR POSITIVE 481 0.0832
35 BLOOD CALCIUM DECREASED 909 0.0808
36 PERIPHERAL VENOUS DISEASE 328 0.0802
37 HYPERTHYROIDISM 1148 0.0792
38 COELIAC DISEASE 761 0.0775
39 BLOOD PRESSURE SYSTOLIC INCREASED 1473 0.0755
40 FACIAL PAIN 659 0.0737
41 PNEUMONIA VIRAL 231 0.0724
42 BURSITIS 876 0.0721
43 FIBROMYALGIA 1721 0.0707
44 MALABSORPTION 362 0.0693
45 FULL BLOOD COUNT ABNORMAL 732 0.0691
46 SCIATICA 1098 0.0688
47 THYROID MASS 262 0.0682
48 BODY TEMPERATURE DECREASED 669 0.0679
49 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 475 0.0662
50 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 428 0.0658
51 DUODENAL ULCER PERFORATION 490 0.0658
52 DIFFICULTY IN WALKING 225 0.0653
53 MULTIPLE ALLERGIES 506 0.0645
54 AUTOIMMUNE DISORDER 619 0.0634
55 CARDIAC MURMUR 549 0.0634
56 ORTHOSTATIC HYPOTENSION 1080 0.0620
57 ARTERIOSCLEROSIS CORONARY ARTERY 406 0.0612
58 SEASONAL ALLERGY 864 0.0610
59 INTERVERTEBRAL DISC DEGENERATION 560 0.0605
60 SPINAL OSTEOARTHRITIS 526 0.0598
61 CARPAL TUNNEL SYNDROME 836 0.0596
62 DIVERTICULUM 424 0.0596
63 MUSCLE INJURY 494 0.0596
64 SPINAL COLUMN STENOSIS 281 0.0594
65 TENDERNESS 619 0.0593
66 BLOOD PRESSURE DIASTOLIC INCREASED 274 0.0593
67 SPINAL STENOSIS 245 0.0593
68 VASCULITIS 690 0.0592
69 DIABETIC NEUROPATHY 293 0.0591
70 OBSTRUCTIVE AIRWAYS DISORDER 656 0.0589
71 PRE-EXISTING CONDITION IMPROVED 366 0.0586
72 THYROID CANCER 705 0.0585
73 PERICARDITIS 984 0.0585
74 OSTEOARTHRITIS 2465 0.0581
75 HELICOBACTER INFECTION 592 0.0575
76 HYPERLIPIDAEMIA 688 0.0575
77 SINUS CONGESTION 776 0.0574
78 BODY HEIGHT DECREASED 614 0.0574
79 HAEMORRHAGIC ANAEMIA 252 0.0573
80 ONYCHOCLASIS 387 0.0562
81 BLOOD CALCIUM INCREASED 491 0.0559
82 SUBARACHNOID HAEMORRHAGE 569 0.0558
83 SLEEP APNOEA SYNDROME 1065 0.0557
84 BLOOD TEST ABNORMAL 783 0.0557
85 TEMPERATURE INTOLERANCE 575 0.0557
86 NEPHROGENIC ANAEMIA 258 0.0556
87 LIP DRY 498 0.0548
88 VITAMIN D DEFICIENCY 534 0.0547
89 ARTERIAL OCCLUSIVE DISEASE 429 0.0545
90 WALKING AID USER 359 0.0544
91 BLOOD CHOLESTEROL INCREASED 2533 0.0543
92 BLOOD PRESSURE FLUCTUATION 1300 0.0541
93 SPUTUM DISCOLOURED 513 0.0540
94 UPPER-AIRWAY COUGH SYNDROME 445 0.0540
95 PHARYNGOLARYNGEAL PAIN 287 0.0539
96 RED BLOOD CELL SEDIMENTATION RATE INCREASED 597 0.0539
97 SYNOVITIS 968 0.0536
98 JOINT RANGE OF MOTION DECREASED 720 0.0536
99 HIATUS HERNIA 691 0.0533
100 RENAL FAILURE CHRONIC 409 0.0531
101 AORTIC VALVE INCOMPETENCE 225 0.0528
102 GINGIVAL PAIN 420 0.0527
103 TRICUSPID VALVE INCOMPETENCE 418 0.0526
104 RHINITIS 422 0.0523
105 BRONCHIECTASIS 351 0.0520
106 GANGRENE 313 0.0519
107 RALES 300 0.0516
108 MITRAL VALVE INCOMPETENCE 583 0.0515
109 HAIR DISORDER 421 0.0510
110 GRIP STRENGTH DECREASED 446 0.0506
111 BLOOD PRESSURE INADEQUATELY CONTROLLED 303 0.0503
112 HAIR TEXTURE ABNORMAL 670 0.0500
113 LIVE BIRTH 419 0.0500
114 PULMONARY FIBROSIS 956 0.0498
115 SENSORY LOSS 401 0.0498
116 PALPITATIONS 5818 0.0496
117 INFUSION SITE SWELLING 311 0.0494
118 RENAL CYST 392 0.0493
119 HYPERCHOLESTEROLAEMIA 469 0.0485
120 FOLLICULITIS 506 0.0482
121 RECALLED PRODUCT ADMINISTERED 460 0.0482
122 SYNOVIAL CYST 222 0.0480
123 SINUS DISORDER 949 0.0479
124 CHOLECYSTITIS CHRONIC 320 0.0478
125 CYSTITIS 1522 0.0477
126 TRANSIENT ISCHAEMIC ATTACK 1598 0.0473
127 GASTROOESOPHAGEAL REFLUX DISEASE 3799 0.0471
128 IRRITABLE BOWEL SYNDROME 1009 0.0470
129 LOWER LIMB FRACTURE 903 0.0470
130 EXOSTOSIS 429 0.0469
131 WOUND INFECTION 513 0.0468
132 ARTERIOSCLEROSIS 440 0.0467
133 HAND DEFORMITY 613 0.0467
134 WEIGHT LOSS POOR 236 0.0461
135 HEART RATE DECREASED 1620 0.0461
136 TYPE 2 DIABETES MELLITUS 1552 0.0461
137 VITAMIN D DECREASED 392 0.0458
138 PERIPHERAL VASCULAR DISORDER 234 0.0454
139 FOOD ALLERGY 350 0.0453
140 ANOSMIA 653 0.0451
141 HAEMORRHOIDS 877 0.0449
142 GLOSSODYNIA 1005 0.0448
143 SINUSITIS 4594 0.0448
144 ATELECTASIS 433 0.0448
145 GLUCOSE TOLERANCE IMPAIRED 265 0.0448
146 STRESS FRACTURE 241 0.0446
147 DIPLOPIA 1157 0.0445
148 VENTRICULAR TACHYCARDIA 735 0.0445
149 FEELING JITTERY 846 0.0443
150 ORAL PAIN 994 0.0443
151 VARICOSE VEIN 229 0.0443
152 CATARACT OPERATION 263 0.0443
153 SCOLIOSIS 274 0.0442
154 OBESITY 704 0.0441
155 NEUROLOGICAL SYMPTOM 252 0.0440
156 PSYCHOLOGICAL TRAUMA 380 0.0440
157 NERVE COMPRESSION 405 0.0438
158 HEART RATE IRREGULAR 983 0.0435
159 RESPIRATORY TRACT CONGESTION 691 0.0434
160 WEIGHT FLUCTUATION 455 0.0434
161 PAROSMIA 328 0.0434
162 PELVIC FRACTURE 338 0.0434
163 INCREASED UPPER AIRWAY SECRETION 222 0.0432
164 OSTEOPENIA 655 0.0431
165 EAR PAIN 839 0.0431
166 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 731 0.0430
167 STOMACH DISCOMFORT 222 0.0429
168 OEDEMA PERIPHERAL 5226 0.0428
169 BLOOD MAGNESIUM DECREASED 369 0.0427
170 JAW DISORDER 234 0.0427
171 WHEEZING 2528 0.0426
172 INFUSION SITE ERYTHEMA 359 0.0425
173 ARTHRITIS 3349 0.0425
174 CARDIAC FLUTTER 275 0.0425
175 BLOOD PRESSURE INCREASED 6498 0.0425
176 INCREASED TENDENCY TO BRUISE 391 0.0425
177 DYSPNOEA EXERTIONAL 1600 0.0424
178 PULMONARY MASS 631 0.0423
179 CARDIOMEGALY 520 0.0422
180 TOOTH FRACTURE 466 0.0422
181 NIGHT SWEATS 1349 0.0418
182 MIDDLE INSOMNIA 778 0.0416
183 POLYP 272 0.0415
184 NAIL DISORDER 362 0.0413
185 GASTROINTESTINAL MOTILITY DISORDER 221 0.0412
186 ROTATOR CUFF SYNDROME 529 0.0412
187 TOOTH ABSCESS 418 0.0410
188 MUSCULOSKELETAL PAIN 2146 0.0409
189 VISUAL DISTURBANCE 235 0.0409
190 EAR DISCOMFORT 420 0.0409
191 ANOREXIA 527 0.0409
192 BRONCHITIS 3024 0.0408
193 BLOOD SODIUM DECREASED 769 0.0408
194 COGNITIVE DISORDER 1903 0.0407
195 HAIR COLOUR CHANGES 507 0.0407
196 HEART RATE INCREASED 4028 0.0406
197 TINNITUS 1867 0.0406
198 FEELING COLD 1129 0.0405
199 ALOPECIA 7944 0.0404
200 PRODUCTIVE COUGH 1930 0.0404
201 BREAST MASS 271 0.0403
202 DRY MOUTH 3267 0.0402
203 MUSCULOSKELETAL CHEST PAIN 622 0.0401
204 COORDINATION ABNORMAL 558 0.0400
205 IRON DEFICIENCY ANAEMIA 368 0.0398
206 INFUSION SITE PAIN 513 0.0398
207 EXERCISE TOLERANCE DECREASED 229 0.0398
208 CONTUSION 3817 0.0396
209 ULCER HAEMORRHAGE 268 0.0396
210 MUSCLE TWITCHING 912 0.0395
211 EYE PAIN 2231 0.0395
212 HAEMATOCRIT DECREASED 780 0.0393
213 BLOOD POTASSIUM DECREASED 1182 0.0393
214 AFFECT LABILITY 378 0.0392
215 GALLBLADDER DISORDER 701 0.0392
216 ECCHYMOSIS 269 0.0392
217 WEIGHT INCREASED 8761 0.0391
218 MUSCULOSKELETAL DISCOMFORT 673 0.0391
219 VENTRICULAR EXTRASYSTOLES 406 0.0391
220 NODULE 510 0.0390
221 CONCUSSION 302 0.0390
222 BALANCE DISORDER 3368 0.0389
223 WOUND 1089 0.0389
224 FOOT FRACTURE 737 0.0388
225 MADAROSIS 450 0.0387
226 SINUS HEADACHE 230 0.0387
227 DENTAL CARIES 428 0.0387
228 ENERGY INCREASED 228 0.0386
229 INITIAL INSOMNIA 396 0.0386
230 FOOT DEFORMITY 427 0.0385
231 INTERVERTEBRAL DISC PROTRUSION 840 0.0384
232 EXTRASYSTOLES 268 0.0384
233 NERVOUSNESS 2005 0.0383
234 BLOOD IRON DECREASED 455 0.0383
235 PEMPHIGUS 479 0.0383
236 WRIST FRACTURE 458 0.0382
237 DYSPHONIA 2233 0.0381
238 MOBILITY DECREASED 2737 0.0381
239 RIB FRACTURE 778 0.0378
240 NECK PAIN 2113 0.0378
241 URINE ODOUR ABNORMAL 222 0.0377
242 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1813 0.0377
243 LIGAMENT SPRAIN 373 0.0377
244 MUSCULAR WEAKNESS 4287 0.0377
245 LYMPHOEDEMA 260 0.0376
246 SKIN HAEMORRHAGE 557 0.0375
247 ORAL DISCOMFORT 522 0.0375
248 DIVERTICULITIS 1040 0.0375
249 SKIN LACERATION 407 0.0374
250 MOTOR DYSFUNCTION 381 0.0373
251 MICTURITION URGENCY 427 0.0373
252 RENAL FAILURE ACUTE 1586 0.0373
253 JOINT DISLOCATION 394 0.0372
254 OSTEOPOROSIS 1533 0.0372
255 PHARMACEUTICAL PRODUCT COMPLAINT 967 0.0372
256 ELECTROCARDIOGRAM ABNORMAL 292 0.0372
257 EATING DISORDER 792 0.0372
258 PERIPHERAL COLDNESS 510 0.0371
259 MENISCUS INJURY 228 0.0370
260 OEDEMA 2008 0.0370
261 NOCTURIA 449 0.0370
262 SLUGGISHNESS 377 0.0369
263 GROIN PAIN 324 0.0369
264 HIP ARTHROPLASTY 565 0.0369
265 HEPATIC STEATOSIS 684 0.0367
266 SNEEZING 823 0.0367
267 BLOOD UREA INCREASED 614 0.0366
268 HEMIPLEGIA 305 0.0366
269 IMPAIRED HEALING 1202 0.0366
270 SENSATION OF FOREIGN BODY 308 0.0365
271 UTERINE LEIOMYOMA 267 0.0365
272 OESOPHAGITIS 398 0.0364
273 DYSPEPSIA 3581 0.0364
274 AMNESIA 2363 0.0363
275 DRY THROAT 369 0.0363
276 KNEE ARTHROPLASTY 764 0.0363
277 TOOTH INFECTION 478 0.0362
278 ATRIAL FIBRILLATION 3531 0.0362
279 CORONARY ARTERY OCCLUSION 497 0.0362
280 HYSTERECTOMY 313 0.0361
281 ASTHMA 4080 0.0361
282 NASAL DRYNESS 226 0.0360
283 SEDATION 944 0.0360
284 CHOLELITHIASIS 1181 0.0360
285 ANGINA PECTORIS 1031 0.0359
286 POOR QUALITY SLEEP 774 0.0359
287 ARTHROPATHY 1995 0.0359
288 POOR VENOUS ACCESS 371 0.0358
289 GASTRITIS 939 0.0356
290 LIP SWELLING 1188 0.0356
291 HYPERTENSION 7527 0.0355
292 BLOOD COUNT ABNORMAL 537 0.0354
293 MUSCLE SPASTICITY 435 0.0354
294 OXYGEN SATURATION DECREASED 1984 0.0353
295 FOREIGN BODY SENSATION IN EYES 225 0.0353
296 CHEST PAIN 6515 0.0351
297 CATARACT 2094 0.0351
298 RHINORRHOEA 2272 0.0351
299 MUSCLE STRAIN 304 0.0351
300 ARTHROPOD BITE 260 0.0350
301 URINARY TRACT INFECTION 5981 0.0350
302 CONSTIPATION 7640 0.0350
303 WEIGHT DECREASED 9764 0.0349
304 DEHYDRATION 4660 0.0349
305 NASAL CONGESTION 2051 0.0349
306 LACERATION 328 0.0348
307 JOINT SWELLING 4206 0.0348
308 ORAL CANDIDIASIS 458 0.0347
309 FEELING ABNORMAL 8322 0.0347
310 TONGUE DISORDER 251 0.0347
311 RESTLESS LEGS SYNDROME 630 0.0346
312 LOW DENSITY LIPOPROTEIN INCREASED 268 0.0346
313 FALL 11497 0.0345
314 INSOMNIA 9193 0.0345
315 GOUT 619 0.0345
316 APHONIA 481 0.0344
317 ELECTROLYTE IMBALANCE 400 0.0344
318 LOWER GASTROINTESTINAL HAEMORRHAGE 254 0.0343
319 ATRIAL FLUTTER 274 0.0343
320 ASPIRATION 376 0.0343
321 HYPERSOMNIA 984 0.0343
322 FREQUENT BOWEL MOVEMENTS 927 0.0343
323 ASTHENIA 12888 0.0342
324 MUSCULOSKELETAL STIFFNESS 3000 0.0342
325 RASH PAPULAR 767 0.0342
326 THROAT IRRITATION 1535 0.0342
327 FLUSHING 3463 0.0340
328 ADRENAL INSUFFICIENCY 413 0.0340
329 UPPER RESPIRATORY TRACT INFECTION 1572 0.0340
330 APPETITE DISORDER 225 0.0339
331 TOOTH DISORDER 754 0.0339
332 MIGRAINE 3236 0.0339
333 ATRIAL SEPTAL DEFECT 283 0.0338
334 CELLULITIS 1702 0.0337
335 INTERNATIONAL NORMALISED RATIO INCREASED 962 0.0337
336 BLADDER DISORDER 335 0.0337
337 FEELING HOT 2067 0.0337
338 OROPHARYNGEAL PAIN 3120 0.0337
339 LUNG DISORDER 1646 0.0336
340 EYE INFECTION 379 0.0335
341 LUNG INFILTRATION 296 0.0335
342 MACULAR DEGENERATION 400 0.0335
343 RECTAL HAEMORRHAGE 1437 0.0334
344 BLOOD TRIGLYCERIDES INCREASED 591 0.0334
345 MUSCLE SPASMS 6131 0.0334
346 EAR INFECTION 888 0.0333
347 PULMONARY HYPERTENSION 695 0.0333
348 ACTIVITIES OF DAILY LIVING IMPAIRED 660 0.0333
349 DYSGEUSIA 2468 0.0332
350 CHOLECYSTECTOMY 379 0.0331
351 SWOLLEN TONGUE 1036 0.0331
352 CORONARY ARTERY DISEASE 1003 0.0331
353 RHEUMATOID ARTHRITIS 3759 0.0331
354 FEMUR FRACTURE 1025 0.0331
355 BLOOD POTASSIUM INCREASED 537 0.0330
356 FATIGUE 25703 0.0330
357 EYE PRURITUS 1109 0.0330
358 CHEST DISCOMFORT 3371 0.0329
359 ABDOMINAL DISTENSION 3436 0.0329
360 FLATULENCE 1863 0.0328
361 DISTURBANCE IN ATTENTION 1769 0.0328
362 PAIN IN EXTREMITY 9643 0.0327
363 BACK PAIN 7596 0.0327
364 HAIR GROWTH ABNORMAL 226 0.0326
365 JOINT EFFUSION 225 0.0326
366 LARGE INTESTINE POLYP 226 0.0326
367 UPPER LIMB FRACTURE 649 0.0325
368 BONE DISORDER 593 0.0325
369 GASTROENTERITIS VIRAL 587 0.0325
370 ANAL INCONTINENCE 292 0.0324
371 HOT FLUSH 2445 0.0324
372 PHOTOPHOBIA 610 0.0324
373 BLOOD ALBUMIN DECREASED 257 0.0324
374 FEELING DRUNK 240 0.0323
375 STOMATITIS 1954 0.0322
376 URINARY INCONTINENCE 954 0.0322
377 SCAR 551 0.0322
378 ANKLE FRACTURE 497 0.0321
379 VERTIGO 1954 0.0320
380 OCULAR DISCOMFORT 359 0.0319
381 PRURITUS GENERALISED 691 0.0319
382 HEMIPARESIS 541 0.0319
383 LIMB INJURY 867 0.0319
384 ABDOMINAL PAIN UPPER 6569 0.0319
385 DECREASED ACTIVITY 344 0.0319
386 JOINT STIFFNESS 836 0.0318
387 MUSCLE DISORDER 258 0.0318
388 PERIPHERAL SWELLING 4900 0.0318
389 PRESCRIBED OVERDOSE 615 0.0318
390 HYPERHIDROSIS 4092 0.0317
391 KIDNEY INFECTION 623 0.0317
392 ROAD TRAFFIC ACCIDENT 1327 0.0317
393 JOINT INJURY 676 0.0316
394 COUGH 8869 0.0316
395 BURNING SENSATION 2216 0.0316
396 CARDIAC FAILURE CONGESTIVE 2534 0.0315
397 RESPIRATORY RATE INCREASED 280 0.0315
398 HYPERAESTHESIA 259 0.0315
399 OVARIAN CYST 315 0.0315
400 MYALGIA 5352 0.0314
401 FORMICATION 219 0.0314
402 ANXIETY 8956 0.0314
403 ARTHRALGIA 13082 0.0314
404 SLEEP DISORDER 2217 0.0314
405 APHASIA 947 0.0313
406 BLISTER 1761 0.0313
407 PAIN IN JAW 888 0.0313
408 ABDOMINAL DISCOMFORT 5256 0.0313
409 THROAT TIGHTNESS 847 0.0313
410 MALNUTRITION 350 0.0313
411 POLLAKIURIA 1304 0.0312
412 FLUID RETENTION 1590 0.0312
413 HERPES ZOSTER 1795 0.0312
414 THINKING ABNORMAL 582 0.0312
415 LIVER FUNCTION TEST ABNORMAL 908 0.0312
416 HYPONATRAEMIA 1755 0.0311
417 HYPOAESTHESIA 4659 0.0311
418 ORAL DISORDER 228 0.0311
419 SPINAL COMPRESSION FRACTURE 257 0.0311
420 LOCAL SWELLING 541 0.0310
421 GLOMERULAR FILTRATION RATE DECREASED 381 0.0310
422 HAEMOPTYSIS 864 0.0309
423 DYSPHAGIA 2940 0.0309
424 SPINAL DISORDER 293 0.0309
425 MUSCLE TIGHTNESS 501 0.0309
426 SYSTEMIC LUPUS ERYTHEMATOSUS 1097 0.0309
427 IMPAIRED DRIVING ABILITY 351 0.0308
428 DERMATITIS CONTACT 352 0.0308
429 LETHARGY 1774 0.0308
430 FLANK PAIN 289 0.0308
431 DRY EYE 1537 0.0308
432 HEAD INJURY 974 0.0307
433 SINUS BRADYCARDIA 297 0.0307
434 DIZZINESS 15276 0.0306
435 TREMOR 5077 0.0306
436 PRODUCT ADMINISTRATION INTERRUPTED 240 0.0305
437 SECRETION DISCHARGE 382 0.0305
438 CYST 378 0.0304
439 DECUBITUS ULCER 248 0.0304
440 ABNORMAL FAECES 249 0.0304
441 HIP FRACTURE 976 0.0303
442 ABASIA 749 0.0303
443 TROPONIN INCREASED 230 0.0302
444 BONE PAIN 1769 0.0302
445 EYE SWELLING 1123 0.0302
446 GLAUCOMA 581 0.0301
447 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1574 0.0301
448 RESPIRATORY TRACT INFECTION 785 0.0301
449 HEPATIC ENZYME INCREASED 2051 0.0301
450 FAECES DISCOLOURED 652 0.0300
451 HEADACHE 18849 0.0300
452 NASOPHARYNGITIS 5540 0.0300
453 CHOLECYSTITIS 358 0.0300
454 BLOOD PRESSURE ABNORMAL 597 0.0300
455 MASS 419 0.0299
456 TOOTHACHE 541 0.0299
457 SUPRAVENTRICULAR TACHYCARDIA 286 0.0298
458 SPINAL FRACTURE 597 0.0298
459 SWELLING 2783 0.0297
460 BLOOD ALKALINE PHOSPHATASE INCREASED 738 0.0297
461 HAEMOGLOBIN DECREASED 3051 0.0297
462 TENDONITIS 460 0.0297
463 DYSURIA 1092 0.0296
464 DRUG INTOLERANCE 2864 0.0296
465 RASH PRURITIC 1605 0.0296
466 DIABETES MELLITUS INADEQUATE CONTROL 524 0.0296
467 ERUCTATION 572 0.0295
468 MENTAL STATUS CHANGES 821 0.0295
469 GAIT INABILITY 987 0.0295
470 PETECHIAE 308 0.0295
471 CONFUSIONAL STATE 4762 0.0294
472 GAIT DISTURBANCE 5639 0.0294
473 PSORIATIC ARTHROPATHY 1192 0.0293
474 IMPAIRED QUALITY OF LIFE 422 0.0293
475 BLOOD PRESSURE DECREASED 1949 0.0293
476 HEAD DISCOMFORT 519 0.0293
477 POST PROCEDURAL INFECTION 238 0.0292
478 CONTRAINDICATED PRODUCT ADMINISTERED 884 0.0292
479 PARAESTHESIA 4593 0.0292
480 DIZZINESS POSTURAL 283 0.0292
481 BACK DISORDER 474 0.0291
482 INTENTIONAL PRODUCT USE ISSUE 2552 0.0291
483 LABORATORY TEST ABNORMAL 859 0.0291
484 LACRIMATION INCREASED 879 0.0291
485 RED BLOOD CELL COUNT DECREASED 831 0.0290
486 PULMONARY CONGESTION 383 0.0290
487 RETCHING 619 0.0290
488 LOWER RESPIRATORY TRACT INFECTION 1317 0.0289
489 DEPRESSED LEVEL OF CONSCIOUSNESS 1144 0.0289
490 AORTIC ANEURYSM 220 0.0289
491 NEURALGIA 703 0.0289
492 APHTHOUS ULCER 224 0.0289
493 THIRST 516 0.0289
494 DYSPNOEA 16343 0.0288
495 INCONTINENCE 305 0.0288
496 HYPERGLYCAEMIA 1051 0.0288
497 INCREASED APPETITE 551 0.0288
498 GENERAL PHYSICAL HEALTH DETERIORATION 3332 0.0288
499 DIABETES MELLITUS 2195 0.0288
500 NEPHROLITHIASIS 1316 0.0287
501 DEEP VEIN THROMBOSIS 1864 0.0287
502 DEPRESSION 6519 0.0286
503 INJURY 2013 0.0286
504 INFLUENZA LIKE ILLNESS 2355 0.0286
505 TACHYCARDIA 2538 0.0285
506 EMPHYSEMA 288 0.0285
507 SENSORY DISTURBANCE 458 0.0285
508 ULCER 454 0.0285
509 DYSSTASIA 832 0.0285
510 BLOOD URINE PRESENT 540 0.0284
511 BLOOD CREATININE INCREASED 1856 0.0284
512 PHARYNGEAL OEDEMA 437 0.0284
513 INFUSION RELATED REACTION 1879 0.0283
514 BACK INJURY 308 0.0283
515 EYE DISCHARGE 294 0.0283
516 DIARRHOEA 18259 0.0283
517 DECREASED APPETITE 6569 0.0283
518 DYSARTHRIA 1063 0.0282
519 C-REACTIVE PROTEIN INCREASED 1027 0.0282
520 BODY TEMPERATURE INCREASED 575 0.0282
521 AGEUSIA 703 0.0282
522 HOSPICE CARE 278 0.0281
523 GASTROINTESTINAL PAIN 309 0.0281
524 HYPOTENSION 5624 0.0280
525 HAEMATOCHEZIA 1547 0.0280
526 HYPERCALCAEMIA 346 0.0280
527 BLOOD GLUCOSE FLUCTUATION 307 0.0280
528 BASAL CELL CARCINOMA 437 0.0280
529 VITREOUS FLOATERS 275 0.0279
530 GASTRIC DISORDER 960 0.0279
531 BRAIN FOG 438 0.0279
532 PLEURAL EFFUSION 1700 0.0279
533 INFLAMMATION 1440 0.0279
534 GASTROENTERITIS 407 0.0279
535 NASAL DISCOMFORT 221 0.0278
536 MYOCARDIAL ISCHAEMIA 317 0.0278
537 GASTROINTESTINAL DISORDER 2490 0.0278
538 NAUSEA 21987 0.0278
539 DISORIENTATION 1097 0.0277
540 HYPOXIA 973 0.0276
541 CRYING 1004 0.0276
542 VISION BLURRED 3792 0.0276
543 LOCALISED INFECTION 667 0.0276
544 FUNGAL INFECTION 919 0.0275
545 MALAISE 12087 0.0275
546 MEMORY IMPAIRMENT 3784 0.0275
547 LIMB DISCOMFORT 852 0.0275
548 CHOKING 537 0.0275
549 HYPOKALAEMIA 1270 0.0275
550 LIVER INJURY 675 0.0275
551 PHARYNGITIS 341 0.0275
552 COAGULOPATHY 458 0.0275
553 SKIN ULCER 710 0.0274
554 SYNCOPE 2748 0.0274
555 PAIN OF SKIN 739 0.0274
556 EYE DISORDER 902 0.0274
557 MALIGNANT MELANOMA 367 0.0274
558 PARAESTHESIA ORAL 395 0.0274
559 EOSINOPHIL COUNT INCREASED 228 0.0273
560 SOMNOLENCE 5492 0.0272
561 EPISTAXIS 2040 0.0272
562 POLYURIA 223 0.0272
563 ABDOMINAL PAIN 6328 0.0272
564 FEAR 731 0.0271
565 PRESYNCOPE 660 0.0271
566 BIPOLAR DISORDER 295 0.0271
567 PANIC ATTACK 989 0.0271
568 SWELLING FACE 1766 0.0271
569 ANAEMIA 5172 0.0271
570 RENAL DISORDER 1263 0.0271
571 HAEMATOMA 701 0.0270
572 OSTEOMYELITIS 489 0.0270
573 WHITE BLOOD CELL COUNT INCREASED 1036 0.0270
574 PRODUCT TASTE ABNORMAL 365 0.0269
575 FULL BLOOD COUNT DECREASED 543 0.0269
576 DISCOMFORT 1640 0.0269
577 SKIN DISORDER 896 0.0268
578 HEPATIC CIRRHOSIS 504 0.0268
579 INFLUENZA 2986 0.0267
580 LIVER DISORDER 1186 0.0267
581 IMMUNODEFICIENCY 398 0.0267
582 COLD SWEAT 470 0.0266
583 PSYCHOMOTOR HYPERACTIVITY 442 0.0266
584 CHILLS 3118 0.0266
585 HUNGER 370 0.0265
586 BREAST PAIN 283 0.0265
587 TOOTH EXTRACTION 330 0.0265
588 PLATELET COUNT INCREASED 345 0.0264
589 PULMONARY EMBOLISM 2508 0.0264
590 PAIN 16164 0.0263
591 URINE OUTPUT DECREASED 230 0.0263
592 HERNIA 508 0.0262
593 PNEUMONIA 8501 0.0262
594 HYPOPHAGIA 669 0.0261
595 HYPOCALCAEMIA 495 0.0261
596 OROPHARYNGEAL DISCOMFORT 236 0.0261
597 CLOSTRIDIUM DIFFICILE COLITIS 277 0.0261
598 GENERALISED OEDEMA 323 0.0261
599 PRESCRIBED UNDERDOSE 519 0.0260
600 UROSEPSIS 240 0.0260
601 CHROMATURIA 587 0.0260
602 ARRHYTHMIA 1231 0.0260
603 ORAL HERPES 507 0.0259
604 VIRAL INFECTION 864 0.0259
605 PRODUCT SUBSTITUTION ISSUE 1494 0.0259
606 EYE HAEMORRHAGE 346 0.0259
607 SKIN INFECTION 290 0.0258
608 HYPOMAGNESAEMIA 359 0.0258
609 EYE IRRITATION 1483 0.0257
610 HYPOGLYCAEMIA 1246 0.0257
611 ACUTE RESPIRATORY FAILURE 494 0.0257
612 POST PROCEDURAL COMPLICATION 493 0.0256
613 GASTROINTESTINAL INFECTION 230 0.0256
614 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1825 0.0256
615 MYOSITIS 230 0.0256
616 HYPOKINESIA 372 0.0256
617 PHARYNGITIS STREPTOCOCCAL 277 0.0256
618 WRONG TECHNIQUE IN DRUG USAGE PROCESS 926 0.0255
619 EYELID PTOSIS 259 0.0255
620 BLOOD GLUCOSE DECREASED 1221 0.0254
621 PYELONEPHRITIS 220 0.0254
622 ADVERSE DRUG REACTION 2280 0.0254
623 INSURANCE ISSUE 388 0.0253
624 LUPUS-LIKE SYNDROME 230 0.0253
625 GRAND MAL CONVULSION 234 0.0253
626 PERICARDIAL EFFUSION 584 0.0252
627 LYMPHADENOPATHY 894 0.0252
628 DRUG LEVEL INCREASED 418 0.0252
629 THERAPEUTIC RESPONSE UNEXPECTED 1132 0.0252
630 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 223 0.0252
631 EYELID OEDEMA 293 0.0252
632 GINGIVAL BLEEDING 344 0.0252
633 THERAPEUTIC PRODUCT EFFECT DECREASED 1127 0.0251
634 URTICARIA 4209 0.0251
635 PRODUCT ODOUR ABNORMAL 263 0.0251
636 GASTRIC ULCER 477 0.0251
637 PRURITUS 9642 0.0251
638 MENTAL IMPAIRMENT 608 0.0251
639 HYPOAESTHESIA ORAL 378 0.0251
640 BLINDNESS 1020 0.0250
641 IMPAIRED GASTRIC EMPTYING 341 0.0250
642 RESPIRATORY DISORDER 748 0.0250
643 IMMUNE SYSTEM DISORDER 329 0.0249
644 INJECTION SITE HAEMATOMA 362 0.0249
645 UNEVALUABLE EVENT 1886 0.0249
646 BRAIN NEOPLASM 229 0.0249
647 ABDOMINAL PAIN LOWER 630 0.0249
648 FEEDING DISORDER 505 0.0249
649 SKIN DISCOLOURATION 1139 0.0248
650 BEDRIDDEN 325 0.0247
651 END STAGE RENAL DISEASE 450 0.0246
652 HEPATOMEGALY 242 0.0246
653 VOMITING 11558 0.0246
654 SMALL INTESTINAL OBSTRUCTION 302 0.0245
655 ECONOMIC PROBLEM 371 0.0245
656 UPPER GASTROINTESTINAL HAEMORRHAGE 411 0.0244
657 VISUAL IMPAIRMENT 3005 0.0242
658 BREAST CANCER FEMALE 647 0.0242
659 TENDON RUPTURE 298 0.0241
660 ABNORMAL DREAMS 666 0.0241
661 HYPERSENSITIVITY 4475 0.0241
662 PHARYNGEAL SWELLING 235 0.0240
663 RASH GENERALISED 621 0.0240
664 BACTERIAL INFECTION 446 0.0239
665 NEPHROPATHY 223 0.0239
666 LOSS OF CONSCIOUSNESS 3047 0.0238
667 MOUTH ULCERATION 501 0.0238
668 NIGHTMARE 822 0.0237
669 DIARRHOEA HAEMORRHAGIC 222 0.0237
670 THROMBOSIS 1908 0.0237
671 HALLUCINATION 1784 0.0236
672 RENAL FAILURE 3143 0.0236
673 DEPRESSED MOOD 1249 0.0236
674 SPEECH DISORDER 1235 0.0235
675 STAPHYLOCOCCAL INFECTION 777 0.0235
676 SKIN LESION 646 0.0235
677 BRADYCARDIA 1249 0.0235
678 NEUROPATHY PERIPHERAL 2239 0.0235
679 CLOSTRIDIUM DIFFICILE INFECTION 513 0.0235
680 MUSCLE ATROPHY 297 0.0234
681 GASTROINTESTINAL HAEMORRHAGE 1959 0.0234
682 RASH MACULAR 817 0.0233
683 CONVULSION 1336 0.0233
684 SPLENOMEGALY 273 0.0233
685 PHOTOSENSITIVITY REACTION 384 0.0232
686 RENAL TUBULAR NECROSIS 228 0.0232
687 ELECTROCARDIOGRAM QT PROLONGED 836 0.0232
688 SCAB 265 0.0232
689 TASTE DISORDER 471 0.0232
690 CONDITION AGGRAVATED 7049 0.0232
691 MOVEMENT DISORDER 744 0.0231
692 LEUKOCYTOSIS 419 0.0231
693 PRODUCT PHYSICAL ISSUE 467 0.0231
694 PANCREATITIS 1218 0.0230
695 COVID-19 4033 0.0230
696 IRRITABILITY 1380 0.0229
697 SCRATCH 242 0.0229
698 HEREDITARY ANGIOEDEMA 246 0.0229
699 NERVE INJURY 254 0.0228
700 IMPAIRED WORK ABILITY 488 0.0228
701 TRANSFUSION 239 0.0228
702 ILLNESS 2348 0.0228
703 PYREXIA 7886 0.0228
704 PALLOR 620 0.0228
705 CANDIDA INFECTION 384 0.0227
706 DRUG INTERACTION 3589 0.0226
707 SPINAL PAIN 265 0.0226
708 HYPERTENSIVE CRISIS 251 0.0225
709 PULMONARY OEDEMA 1009 0.0225
710 QUALITY OF LIFE DECREASED 302 0.0225
711 SPINAL OPERATION 277 0.0225
712 MEDICATION ERROR 1248 0.0224
713 BLOOD GLUCOSE INCREASED 4228 0.0224
714 CARDIAC DISORDER 2096 0.0224
715 ASPARTATE AMINOTRANSFERASE INCREASED 1190 0.0224
716 RASH 9759 0.0224
717 PULMONARY THROMBOSIS 244 0.0224
718 CARDIOMYOPATHY 330 0.0223
719 ACUTE MYOCARDIAL INFARCTION 658 0.0223
720 RESTLESSNESS 816 0.0223
721 PARANOIA 384 0.0223
722 INFECTION 3216 0.0222
723 OCULAR HYPERAEMIA 1051 0.0221
724 DEAFNESS 578 0.0221
725 PRODUCT USE COMPLAINT 348 0.0221
726 WHITE BLOOD CELL COUNT DECREASED 2390 0.0220
727 ATAXIA 261 0.0220
728 COLITIS 833 0.0220
729 SINUS TACHYCARDIA 312 0.0220
730 DEMENTIA 614 0.0219
731 CHRONIC KIDNEY DISEASE 1669 0.0219
732 URINARY RETENTION 731 0.0219
733 LIVER FUNCTION TEST INCREASED 470 0.0219
734 PLATELET COUNT DECREASED 2329 0.0218
735 EMOTIONAL DISORDER 673 0.0218
736 VISUAL ACUITY REDUCED 725 0.0218
737 HYPERKALAEMIA 762 0.0217
738 LYMPHOCYTE COUNT DECREASED 383 0.0216
739 DRY SKIN 2881 0.0216
740 NEUTROPHIL COUNT INCREASED 221 0.0216
741 DRUG EFFECT DECREASED 1159 0.0215
742 RENAL PAIN 228 0.0215
743 DELIRIUM 746 0.0215
744 PRODUCT PRESCRIBING ERROR 512 0.0215
745 CEREBROVASCULAR ACCIDENT 3624 0.0214
746 ANGIOEDEMA 946 0.0214
747 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 496 0.0213
748 INTERNAL HAEMORRHAGE 243 0.0212
749 PREGNANCY 425 0.0212
750 ALANINE AMINOTRANSFERASE INCREASED 1295 0.0211
751 AGITATION 1547 0.0210
752 INJECTION SITE NODULE 231 0.0210
753 INTENTIONAL PRODUCT MISUSE 1837 0.0210
754 TUBULOINTERSTITIAL NEPHRITIS 392 0.0209
755 ILL-DEFINED DISORDER 1267 0.0208
756 ABSCESS 332 0.0208
757 MOOD ALTERED 567 0.0208
758 PRODUCT QUALITY ISSUE 2807 0.0206
759 HAEMATURIA 705 0.0206
760 DRUG TOXICITY 280 0.0205
761 HALLUCINATION, VISUAL 433 0.0205
762 ERYTHEMA 4192 0.0204
763 DYSKINESIA 828 0.0204
764 FLUID OVERLOAD 296 0.0203
765 MANIA 334 0.0203
766 CONJUNCTIVITIS 376 0.0202
767 PANCREATITIS ACUTE 454 0.0202
768 INTESTINAL OBSTRUCTION 758 0.0201
769 SKIN CANCER 433 0.0201
770 UNRESPONSIVE TO STIMULI 517 0.0200
771 SKIN FISSURES 391 0.0200
772 DRUG DISPENSING ERROR 305 0.0199
773 THERAPY NON-RESPONDER 893 0.0198
774 SURGERY 1163 0.0198
775 RASH ERYTHEMATOUS 948 0.0198
776 COLITIS ULCERATIVE 885 0.0198
777 SUBDURAL HAEMATOMA 283 0.0198
778 PRODUCT ADMINISTRATION ERROR 399 0.0197
779 PELVIC PAIN 358 0.0197
780 PNEUMONITIS 535 0.0196
781 EJECTION FRACTION DECREASED 304 0.0195
782 DISABILITY 384 0.0194
783 HAEMATEMESIS 492 0.0194
784 BLOOD CREATINE PHOSPHOKINASE INCREASED 558 0.0194
785 LUNG INFECTION 301 0.0194
786 MUSCULOSKELETAL DISORDER 367 0.0193
787 TRANSAMINASES INCREASED 426 0.0191
788 MULTI-ORGAN FAILURE 330 0.0191
789 MYOCARDIAL INFARCTION 3325 0.0190
790 LYMPHOMA 294 0.0190
791 INTRAOCULAR PRESSURE INCREASED 243 0.0190
792 BLOOD BILIRUBIN INCREASED 512 0.0189
793 GAMMA-GLUTAMYLTRANSFERASE INCREASED 420 0.0189
794 INJECTION SITE IRRITATION 241 0.0189
795 PNEUMONIA ASPIRATION 473 0.0189
796 HYPOACUSIS 815 0.0189
797 DISEASE RECURRENCE 900 0.0189
798 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1346 0.0189
799 RENAL IMPAIRMENT 1587 0.0189
800 MOOD SWINGS 600 0.0188
801 GLYCOSYLATED HAEMOGLOBIN INCREASED 474 0.0188
802 SEPSIS 2094 0.0188
803 SKIN EXFOLIATION 1583 0.0187
804 APATHY 272 0.0186
805 MELAENA 408 0.0185
806 BLOOD GLUCOSE ABNORMAL 341 0.0184
807 ASCITES 540 0.0184
808 INTENTIONAL DRUG MISUSE 384 0.0183
809 RHABDOMYOLYSIS 764 0.0183
810 SKIN REACTION 258 0.0183
811 RESPIRATORY FAILURE 1334 0.0183
812 SARS-COV-2 TEST POSITIVE 241 0.0182
813 INTENTIONAL DOSE OMISSION 519 0.0182
814 LEUKOPENIA 910 0.0182
815 BLINDNESS UNILATERAL 256 0.0181
816 PULMONARY ARTERIAL HYPERTENSION 262 0.0181
817 CARDIAC FAILURE 1449 0.0180
818 ANHEDONIA 473 0.0180
819 RESPIRATORY DISTRESS 496 0.0180
820 MENTAL DISORDER 780 0.0179
821 ANGER 606 0.0179
822 DRUG ADMINISTRATION ERROR 549 0.0179
823 BRONCHOSPASM 255 0.0179
824 INJECTION SITE EXTRAVASATION 220 0.0178
825 TREATMENT NONCOMPLIANCE 971 0.0177
826 DEVICE RELATED INFECTION 273 0.0177
827 HEPATITIS 452 0.0176
828 PRODUCT USE ISSUE 3311 0.0176
829 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 302 0.0176
830 JAUNDICE 474 0.0176
831 BLOOD LACTATE DEHYDROGENASE INCREASED 279 0.0176
832 ECZEMA 917 0.0175
833 RENAL INJURY 520 0.0175
834 DELUSION 271 0.0174
835 OSTEONECROSIS OF JAW 431 0.0174
836 CIRCULATORY COLLAPSE 296 0.0174
837 PNEUMOTHORAX 275 0.0173
838 VAGINAL HAEMORRHAGE 751 0.0173
839 NEOPLASM PROGRESSION 601 0.0173
840 DRUG PRESCRIBING ERROR 332 0.0173
841 ADVERSE REACTION 229 0.0173
842 INJECTION SITE WARMTH 355 0.0172
843 HALLUCINATION, AUDITORY 274 0.0172
844 FRACTURE 323 0.0170
845 INCORRECT DRUG ADMINISTRATION DURATION 478 0.0170
846 SUICIDAL IDEATION 1554 0.0170
847 DRUG DOSE OMISSION 2795 0.0169
848 THERAPEUTIC RESPONSE DECREASED 1022 0.0168
849 PANCYTOPENIA 935 0.0167
850 APPLICATION SITE PRURITUS 379 0.0167
851 PROCEDURAL PAIN 463 0.0167
852 DERMATITIS 348 0.0166
853 FACE OEDEMA 280 0.0166
854 ACUTE KIDNEY INJURY 2534 0.0165
855 ABNORMAL BEHAVIOUR 652 0.0164
856 ISCHAEMIC STROKE 293 0.0164
857 INJECTION SITE ERYTHEMA 2022 0.0163
858 DEVICE FAILURE 248 0.0163
859 APPLICATION SITE ERYTHEMA 426 0.0162
860 HAEMORRHAGE 1694 0.0162
861 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2920 0.0162
862 ACCIDENTAL OVERDOSE 588 0.0161
863 ENCEPHALOPATHY 394 0.0160
864 COLON CANCER 238 0.0160
865 METASTASES TO BONE 262 0.0159
866 DRUG INEFFECTIVE 21013 0.0159
867 INJECTION SITE PRURITUS 1059 0.0158
868 THROMBOCYTOPENIA 1759 0.0157
869 DIALYSIS 222 0.0156
870 MULTIPLE SCLEROSIS 747 0.0156
871 PRODUCT DOSE OMISSION IN ERROR 442 0.0156
872 PSORIASIS 2035 0.0156
873 INJECTION SITE MASS 573 0.0155
874 ANAPHYLACTIC REACTION 856 0.0155
875 METASTASES TO LIVER 270 0.0153
876 PRODUCT DISPENSING ERROR 334 0.0153
877 CEREBRAL HAEMORRHAGE 544 0.0152
878 OFF LABEL USE 13301 0.0152
879 DIABETIC KETOACIDOSIS 364 0.0151
880 MENORRHAGIA 297 0.0151
881 NEOPLASM MALIGNANT 1009 0.0151
882 THERAPY CESSATION 776 0.0151
883 WITHDRAWAL SYNDROME 634 0.0151
884 PROTEINURIA 287 0.0151
885 ADVERSE EVENT 1390 0.0151
886 OSTEONECROSIS 489 0.0149
887 INJECTION SITE HAEMORRHAGE 1187 0.0148
888 METABOLIC ACIDOSIS 475 0.0148
889 CYANOSIS 232 0.0147
890 PRODUCT DOSE OMISSION 961 0.0147
891 HAEMORRHAGE INTRACRANIAL 219 0.0146
892 MATERNAL EXPOSURE DURING PREGNANCY 1290 0.0145
893 SEPTIC SHOCK 627 0.0144
894 INJECTION SITE BRUISING 1134 0.0142
895 EOSINOPHILIA 249 0.0142
896 DRUG EFFECT INCOMPLETE 516 0.0142
897 HEPATIC FAILURE 427 0.0141
898 PRODUCT DOSE OMISSION ISSUE 4146 0.0141
899 EXPIRED PRODUCT ADMINISTERED 468 0.0141
900 CARDIOVASCULAR DISORDER 357 0.0140
901 INJECTION SITE RASH 431 0.0140
902 DRUG ERUPTION 247 0.0139
903 METRORRHAGIA 235 0.0138
904 INTERSTITIAL LUNG DISEASE 666 0.0137
905 INCORRECT DOSE ADMINISTERED 3139 0.0137
906 STEVENS-JOHNSON SYNDROME 305 0.0137
907 NEEDLE ISSUE 398 0.0137
908 INJECTION SITE URTICARIA 334 0.0136
909 SEROTONIN SYNDROME 261 0.0136
910 NERVOUS SYSTEM DISORDER 424 0.0136
911 CARDIAC ARREST 1120 0.0136
912 MUCOSAL INFLAMMATION 355 0.0135
913 INJECTION SITE PAIN 4121 0.0134
914 PSYCHOTIC DISORDER 396 0.0134
915 RASH MACULO-PAPULAR 298 0.0134
916 AGGRESSION 662 0.0132
917 MALIGNANT NEOPLASM PROGRESSION 1354 0.0132
918 NEUTROPHIL COUNT DECREASED 538 0.0132
919 PRODUCT AVAILABILITY ISSUE 297 0.0130
920 INJECTION SITE REACTION 891 0.0129
921 SEIZURE 1490 0.0129
922 TREATMENT FAILURE 1067 0.0129
923 ACUTE RESPIRATORY DISTRESS SYNDROME 227 0.0128
924 AMENORRHOEA 225 0.0128
925 DRUG EXPOSURE DURING PREGNANCY 436 0.0128
926 MULTIPLE SCLEROSIS RELAPSE 877 0.0128
927 COMA 605 0.0127
928 INJECTION SITE SWELLING 972 0.0127
929 THERAPEUTIC RESPONSE SHORTENED 420 0.0127
930 EXPOSURE DURING PREGNANCY 785 0.0126
931 UNDERDOSE 916 0.0125
932 FOETAL EXPOSURE DURING PREGNANCY 1010 0.0124
933 LUNG NEOPLASM MALIGNANT 510 0.0124
934 PLASMA CELL MYELOMA 483 0.0124
935 BREAST CANCER 1148 0.0123
936 EMOTIONAL DISTRESS 1491 0.0123
937 FEBRILE NEUTROPENIA 814 0.0123
938 EPILEPSY 374 0.0122
939 APPLICATION SITE PAIN 269 0.0122
940 PRODUCT USE IN UNAPPROVED INDICATION 3026 0.0122
941 CEREBRAL INFARCTION 290 0.0119
942 DEVICE DISLOCATION 506 0.0116
943 DISEASE PROGRESSION 1370 0.0116
944 RESPIRATORY ARREST 319 0.0116
945 ANAPHYLACTIC SHOCK 298 0.0115
946 BONE DENSITY DECREASED 361 0.0115
947 SKIN BURNING SENSATION 823 0.0115
948 CHOLESTASIS 220 0.0114
949 TOOTH LOSS 236 0.0114
950 HOSPITALISATION 1739 0.0113
951 LACTIC ACIDOSIS 362 0.0112
952 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 609 0.0111
953 NEUTROPENIA 1505 0.0111
954 CARDIO-RESPIRATORY ARREST 459 0.0110
955 DEVICE MALFUNCTION 769 0.0109
956 THERAPY INTERRUPTED 782 0.0109
957 SHOCK 248 0.0108
958 ACNE 814 0.0107
959 ALTERED STATE OF CONSCIOUSNESS 231 0.0107
960 DRUG WITHDRAWAL SYNDROME 927 0.0106
961 ABORTION SPONTANEOUS 416 0.0104
962 MENSTRUATION IRREGULAR 278 0.0104
963 INCORRECT PRODUCT ADMINISTRATION DURATION 220 0.0101
964 PRODUCT ADHESION ISSUE 359 0.0100
965 ERECTILE DYSFUNCTION 252 0.0098
966 SKIN IRRITATION 445 0.0097
967 SUICIDE ATTEMPT 586 0.0097
968 TARDIVE DYSKINESIA 271 0.0096
969 DRUG-INDUCED LIVER INJURY 299 0.0095
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1914 0.0094
971 DEATH 7581 0.0088
972 DEVICE ISSUE 786 0.0088
973 EXPOSURE VIA SKIN CONTACT 224 0.0086
974 TOXICITY TO VARIOUS AGENTS 1439 0.0085
975 DEVICE BREAKAGE 341 0.0084
976 EXTRA DOSE ADMINISTERED 336 0.0083
977 PREMATURE BABY 249 0.0083
978 OVERDOSE 1753 0.0081
979 HEPATIC FUNCTION ABNORMAL 271 0.0073
980 NO ADVERSE EVENT 1312 0.0072
981 DERMATITIS ATOPIC 371 0.0070
982 DEVICE LEAKAGE 305 0.0070
983 COMPLETED SUICIDE 581 0.0070
984 INTENTIONAL OVERDOSE 414 0.0064
985 INCORRECT ROUTE OF DRUG ADMINISTRATION 222 0.0062
986 ACCIDENTAL EXPOSURE TO PRODUCT 546 0.0053
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 223 0.0048
988 PRODUCT STORAGE ERROR 413 0.0047
989 DRUG ABUSE 336 0.0040
990 DEVICE EXPULSION 221 0.0034
991 DRUG DOSE OMISSION BY DEVICE 255 0.0033
992 PROSTATE CANCER 244 0.0030
993 DRUG DEPENDENCE 417 0.0026